Alcoholic cardiomyopathy pathophysiology: Difference between revisions

Jump to navigation Jump to search
m (Bot: Adding CME Category::Cardiology)
 
Line 51: Line 51:
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WH}}
{{WS}}
[[CME Category::Cardiology]]


[[Category:Disease]]
[[Category:Disease]]
[[Category:Cardiology]]
[[Category:Cardiology]]
{{WH}}
{{WS}}

Latest revision as of 19:49, 14 March 2016

Alcoholic cardiomyopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Differentiating Alcoholic cardiomyopathy from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Alcoholic cardiomyopathy pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Alcoholic cardiomyopathy pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Alcoholic cardiomyopathy pathophysiology

CDC on Alcoholic cardiomyopathy pathophysiology

Alcoholic cardiomyopathy pathophysiology in the news

Blogs on Alcoholic cardiomyopathy pathophysiology

Directions to Hospitals Treating Alcoholic cardiomyopathy

Risk calculators and risk factors for Alcoholic cardiomyopathy pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]; Hardik Patel, M.D.

Overview

Alcoholic cardiomyopathy is a type of dilated cardiomyopathy. Both acute and chronic alcohol consumption, in excessive amounts, has been associated with adverse effects on the myocardium leading to non-ischemic dilated cardiomyopathy. It accounts for 21-36% of all cases of non-ischemic dilated cardiomyopathy [1]. The maximum recommended dose of alcohol consumption in US men and women is 14 drinks and 7 drinks respectively. Consumption above these levels has been shown to be associated with the increased risk of alcoholic cardiomyopathy [2]. Pathogenesis of this condition is multi-factorial.

Pathophysiology

Excessive use of alcohol has a direct toxic effect on the heart muscle cells. The heart muscle becomes weakened, subsequently dilates, and cannot pump blood efficiently. The lack of blood flow affects all parts of the body, resulting in damage to multiple tissues and organ systems. Alcohol may also simultaneously be causing direct damage to the liver. [3]

Pathogenesis of alcoholic cardiomyopathy is multi-factorial. Proposed mechanisms of myocardial injury in alcoholic cardiomyopathy include:[4]

  • Ethanol induced apoptosis: Possible mechanisms by which ethanol promotes apoptosis include increased protein levels of pro-apoptotic protein Bax, increased caspase-3 enzyme activity, increased messenger RNA p21 (p21 inhibits cyclin-dependent kinases). [5]
  • Impaired contraction of myocardium due to direct toxicity
  • Inhibition of protein synthesis and decreased myocyte proliferation [6]
  • Activation of renin-angiotensin system (RAS)
  • Inhibition of oxidative phosphorylation
  • Fatty acid ester accumulation: Ethanol interferes with lipid metabolism and fatty acid composition of sarcolemma. Also, calcium content of the sarcoplasmic reticulum is affected by exposure to ethanol. Increased levels of fatty ethyl esters disrupt mitochondrial function. [7]
  • Nutritional deficiency of thiamine
  • Free radical damage [8]
  • Inflammation
  • Inhibition of calcium-myofilament interaction (negative inotropic effect)

Alcoholic cardiomyopathy occurs in two stages: asymptomatic and symptomatic. People consuming >90 grams of alcohol per day for more than 5 years are at increased risk for developing asymptomatic ACM. Those who continue to drink may become symptomatic and develop signs and symptoms of heart failure. [3]

Genetics

Genetic studies have shown that polymorphisms in angiotensin-converting enzyme gene (DD genotype) and mutations in mitochondrial DNA are associated with increased susceptibility to alcoholic cardiomyopathy. [9]

Conditions associated with Alcoholic Cardiomyopathy

Co-morbidities include:

Cardio-protective effects of Alcohol

A prospective study by Abramson JL et al showed that moderate levels of alcohol consumption are associated with decreased risk of heart failure in the older population[10]. Similar results were shown in other studies like the SAVE trial[11] and the Cardiovascular Health Study[12].

Several mechanisms have been put forward to explain these beneficial effects of alcohol on the heart. These include:

Gronbaek et al., showed in his study that wine reduced the risk of CAD more than beer or spirits[13]. This decreased risk was particularly seen in individuals who consumed less than 22 g/alcohol per day in the form of wine (approximately 2 glasses). The consumption of wine tends to reduce the homocysteine levels. Moreover, wine also contains various polyphenols, especially resveratrol, which are thought to be cardio-protective. These polyphenols are thought to prevent LDL oxidation and thrombosis. Other favorable effects of resveratrol include[14]:

References

  1. Skotzko CE, Vrinceanu A, Krueger L, Freudenberger R (2009). "Alcohol use and congestive heart failure: incidence, importance, and approaches to improved history taking". Heart Failure Reviews. 14 (1): 51–5. doi:10.1007/s10741-007-9048-8. PMID 18034302. Unknown parameter |month= ignored (help)
  2. Thun MJ, Peto R, Lopez AD; et al. (1997). "Alcohol consumption and mortality among middle-aged and elderly U.S. adults". The New England Journal of Medicine. 337 (24): 1705–14. doi:10.1056/NEJM199712113372401. PMID 9392695. Unknown parameter |month= ignored (help)
  3. 3.0 3.1 Piano MR (2002). "Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology". Chest. 121 (5): 1638–50. PMID 12006456. Unknown parameter |month= ignored (help)
  4. Iacovoni A, De Maria R, Gavazzi A (2010). "Alcoholic cardiomyopathy". Journal of Cardiovascular Medicine (Hagerstown, Md.). 11 (12): 884–92. doi:10.2459/JCM.0b013e32833833a3. PMID 20308914. Unknown parameter |month= ignored (help)
  5. Jänkälä H, Eklund KK, Kokkonen JO; et al. (2001). "Ethanol infusion increases ANP and p21 gene expression in isolated perfused rat heart". Biochemical and Biophysical Research Communications. 281 (2): 328–33. doi:10.1006/bbrc.2001.4343. PMID 11181050. Unknown parameter |month= ignored (help)
  6. Fernández-Solà J, Lluis M, Sacanella E, Estruch R, Antúnez E, Urbano-Márquez A (2011). "Increased myostatin activity and decreased myocyte proliferation in chronic alcoholic cardiomyopathy". Alcoholism, Clinical and Experimental Research. 35 (7): 1220–9. doi:10.1111/j.1530-0277.2011.01456.x. PMID 21463333. Unknown parameter |month= ignored (help)
  7. Waldenström A (1998). "Alcohol and congestive heart failure". Alcoholism, Clinical and Experimental Research. 22 (7 Suppl): 315S–317S. PMID 9799954. Unknown parameter |month= ignored (help)
  8. Popovici I, Rezuş C, Cosovanu A (2001). "[Enzymatic markers in the alcoholic cardiomyopathy]". Revista Medico-chirurgicală̆ a Societă̆ţ̜ii De Medici Ş̧i Naturaliş̧ti Din Iaş̧i (in Romanian). 105 (3): 504–8. PMID 12092182.
  9. Fernández-Solà J, Nicolás JM, Oriola J; et al. (2002). "Angiotensin-converting enzyme gene polymorphism is associated with vulnerability to alcoholic cardiomyopathy". Annals of Internal Medicine. 137 (5 Part 1): 321–6. PMID 12204015. Unknown parameter |month= ignored (help)
  10. Abramson JL, Williams SA, Krumholz HM, Vaccarino V (2001). "Moderate alcohol consumption and risk of heart failure among older persons". JAMA : the Journal of the American Medical Association. 285 (15): 1971–7. PMID 11308433. Unknown parameter |month= ignored (help)
  11. Aguilar D, Skali H, Moyé LA; et al. (2004). "Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarction". Journal of the American College of Cardiology. 43 (11): 2015–21. doi:10.1016/j.jacc.2004.01.042. PMID 15172406. Unknown parameter |month= ignored (help)
  12. Bryson CL, Mukamal KJ, Mittleman MA; et al. (2006). "The association of alcohol consumption and incident heart failure: the Cardiovascular Health Study". Journal of the American College of Cardiology. 48 (2): 305–11. doi:10.1016/j.jacc.2006.02.066. PMID 16843180. Unknown parameter |month= ignored (help)
  13. Grønbaek M, Deis A, Sørensen TI, Becker U, Schnohr P, Jensen G (1995). "Mortality associated with moderate intakes of wine, beer, or spirits". BMJ (Clinical Research Ed.). 310 (6988): 1165–9. PMC 2549555. PMID 7767150. Unknown parameter |month= ignored (help)
  14. Saremi A, Arora R (2008). "The cardiovascular implications of alcohol and red wine". American Journal of Therapeutics. 15 (3): 265–77. doi:10.1097/MJT.0b013e3180a5e61a. PMID 18496264.

Template:WH Template:WS CME Category::Cardiology